Azaya Therapeutics azayatherapeutics.com


Azaya is a nanotherapy company utilizing a patented drug delivery technology platform. The tumor-targeted technology aims to allow the company to reformulate marketed chemotherapy drugs to increase their safety and effectiveness.

Azaya is a nanotherapy company utilizing a patented drug delivery technology platform. The tumor-targeted technology aims to allow the company to reformulate marketed chemotherapy drugs to increase their safety and effectiveness.

Company (Alive / Active)

Phone: 210-341-6600

Fax:

100 Sandau Road

San Antonio, 78216
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Azaya Therapeutics $1M Sep 16, 2009
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Azaya Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Aura Biosciences

Cambridge, Massachusetts, United States
Alive / ActiveAura Biosciences is a a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates.Login to see details

Pacira Pharmaceuticals

San Diego, California, United States
IPO / Went publicPacira Pharmaceuticals is focused on formulating, developing and manufacturing controlled-release injectable products based on two drug delivery platforms: DepoFoam and Biosphere. Currently the Company is generating revenue with two marketed products: DepoCyt for lymphomatous meningitis and DepoDur for the treatment of post-surgical pain.Login to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)